Send the following on WhatsApp
Continue to ChatGlenmark's favipiravir version shows promise in late-stage COVID-19 trial https://cde.news/glenmarks-favipiravir-version-shows-promise-in-late-stage-covid-19-trial/
Glenmark's favipiravir version shows promise in late-stage COVID-19 trial https://cde.news/glenmarks-favipiravir-version-shows-promise-in-late-stage-covid-19-trial/